Results 31 to 40 of about 87,574 (284)

Subcutaneous Immunoglobulin Replacement Therapy with Hizentra® is Safe and Effective in Children Less Than 5 Years of Age. [PDF]

open access: yes, 2015
BACKGROUND:Hizentra® (IGSC 20%) is a 20% liquid IgG product approved for subcutaneous administration in adults and children 2 years of age and older who have primary immunodeficiency disease (PIDD). There is limited information about the use of IGSC 20 %
Atkinson, Thomas Prescott   +10 more
core   +2 more sources

Intravenous versus subcutaneous immunoglobulin – Authors' reply

open access: yesThe Lancet Neurology, 2018
We thank Ravi Uniyal and colleagues for their comments on our results from the PATH trial1 on subcutaneous immunoglobulin (SCIg) for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (CIDP). They express concern about the relapse rates in the treatment groups and hypothesise the cause being the pharmacokinetics of SCIg.
van Schaik, Ivo N   +149 more
openaire   +5 more sources

Subcutaneous immunoglobulin replacement therapy

open access: yesCurrent Opinion in Allergy & Clinical Immunology, 2013
Rapid subcutaneous immunoglobulin (SCIg) infusions have been used as an important method of delivering replacement immunoglobulin (Ig) to patients with primary immune deficiencies (PIDs) in Europe over the last 25 years. This review provides a comprehensive interpretation of the literature relating to the administration of SCIg and the services that ...
Chapel, H, Gardulf, A
openaire   +2 more sources

Subcutaneus gammaglobulin in primary immunodeficiencies. Experience at the National Institute of Pediatrics and review of literature

open access: yesActa Pediátrica de México, 2014
Primary immunodeficiencies (PID) were first described over 50 years ago. They are hereditary disorders, mostly monogenic diseases that produce immune system dysfunction.
Bustamante Ogando Juan Carlos   +2 more
doaj   +1 more source

Tumor necrosis factor inhibitors in psoriatic arthritis. [PDF]

open access: yes, 2017
INTRODUCTION: Psoriatic arthritis (PsA) is a chronic inflammatory disease that can result in significant disability. With the emergence of tumor necrosis factor inhibitors (TNFi), therapeutic outcomes in PsA have improved substantially.
Kraft, Walter K.   +2 more
core   +2 more sources

Serious Bacterial Infections Acquired During Treatment of Patients Given a Diagnosis of Chronic Lyme Disease - United States. [PDF]

open access: yes, 2017
The term "chronic Lyme disease" is used by some health care providers as a diagnosis for various constitutional, musculoskeletal, and neuropsychiatric symptoms (1,2).
Blackburn, Brian G   +9 more
core   +1 more source

Clearance of therapeutic antibody glycoforms after subcutaneous and intravenous injection in a porcine model

open access: yesmAbs, 2022
A relatively low clearance is one of the prominent favorable features of immunoglobulin G1-based therapeutic monoclonal antibodies (mAbs). Various studies have observed differential clearance of mAb glycoforms, including oligomannose glycoforms, which ...
David Falck   +8 more
doaj   +1 more source

Amino-functionalized poly(l-lactide) lamellar single crystals as a valuable substrate for delivery of HPV16-E7 tumor antigen in vaccine development [PDF]

open access: yes, 2015
Background: Poly(L-lactide) (PLLA) is a biodegradable polymer currently used in many biomedical applications, including the production of resorbable surgical devices, porous scaffolds for tissue engineering, nanoparticles and microparticles for the ...
Accardi, Luisa   +8 more
core   +2 more sources

Maintenance therapy with subcutaneous immunoglobulin in a patient with immune‐mediated neuropathic postural tachycardia syndrome

open access: yesJournal of Translational Autoimmunity, 2021
Aims: We describe the disease course of a 35-year-old female with an autoimmune mediated neuropathic postural tachycardia syndrome (PoTS), who responded to immunoglobulin therapy and stabilized on maintenance therapy with subcutaneous immunoglobulin ...
Kalliopi Pitarokoili   +9 more
doaj   +1 more source

Filariasis of the Axilla in a Patient Returning from Travel Abroad: A Case Report [PDF]

open access: yes, 2012
Background: The term filariasis comprises a group of parasitic infections caused by helminths belonging to different genera in the superfamily Filaroidea.
Alkadhi H   +20 more
core   +1 more source

Home - About - Disclaimer - Privacy